Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Sean Z. Zhao, MD, PhD;Thomas A. Burke, PharmD, MPH;Andrew Whelton, MD, PhD;Heather von Allmen;Scott C. Henderson, MS;

News

Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Oct 1, 2002

Sean Z. Zhao, MD, PhD
Thomas A. Burke, PharmD, MPH

Supplements and Featured PublicationsCardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience

Volume 8

Issue 15 Suppl

Download PDF: Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life Practice

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777